India · Delayed Price · Currency is INR ZR2 Bioenergy Statistics
Total Valuation
ZR2 Bioenergy has a market cap or net worth of INR 1.90 billion. The enterprise value is 1.71 billion.
| Market Cap | 1.90B |
| Enterprise Value | 1.71B |
Important Dates
The next estimated earnings date is Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ZR2 Bioenergy has 15.92 million shares outstanding. The number of shares has decreased by -83.73% in one year.
| Current Share Class | 15.92M |
| Shares Outstanding | 15.92M |
| Shares Change (YoY) | -83.73% |
| Shares Change (QoQ) | -5.15% |
| Owned by Insiders (%) | 4.37% |
| Owned by Institutions (%) | n/a |
| Float | 13.05M |
Valuation Ratios
The trailing PE ratio is 116.62.
| PE Ratio | 116.62 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.36 |
| P/TBV Ratio | 1.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 186.58 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -168.60 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -0.81% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 8.34% |
| Revenue Per Employee | n/a |
| Profits Per Employee | 1.84M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -315,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.98% in the last 52 weeks. The beta is 0.74, so ZR2 Bioenergy's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | -68.98% |
| 50-Day Moving Average | 118.08 |
| 200-Day Moving Average | 179.67 |
| Relative Strength Index (RSI) | 55.77 |
| Average Volume (20 Days) | 210 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -1.21M |
| Operating Income | -9.27M |
| Pretax Income | 8.88M |
| Net Income | 9.19M |
| EBITDA | -6.73M |
| EBIT | -9.27M |
| Earnings Per Share (EPS) | 1.03 |
Balance Sheet
The company has 188.44 million in cash and no debt, with a net cash position of 188.44 million or 11.84 per share.
| Cash & Cash Equivalents | 188.44M |
| Total Debt | n/a |
| Net Cash | 188.44M |
| Net Cash Per Share | 11.84 |
| Equity (Book Value) | 1.40B |
| Book Value Per Share | 394.08 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -6.89 million and capital expenditures -12.34 million, giving a free cash flow of -19.23 million.
| Operating Cash Flow | -6.89M |
| Capital Expenditures | -12.34M |
| Depreciation & Amortization | 2.55M |
| Net Borrowing | n/a |
| Free Cash Flow | -19.23M |
| FCF Per Share | -1.21 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.08%.
| Dividend Per Share | 0.10 |
| Dividend Yield | 0.08% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 83.73% |
| Shareholder Yield | 83.81% |
| Earnings Yield | 0.48% |
| FCF Yield | -1.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 27, 2022. It was a forward split with a ratio of 10.
| Last Split Date | May 27, 2022 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |